ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2103

Reliability of DAS28 in Rheumatoid Arthritis When Based On Patient Self-Assessment of Tender and Swollen Joints

Ole Rintek Madsen and Cecilie Heegaard, Department of Rheumatology/C, Copenhagen University Hospital Gentofte, Hellerup, Denmark

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: outcome measures and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects III: Infections/Risk Factors for Incident Rheumatoid Arthritis/Metrology/Classification/Biomarkers/Predictors of Rheumatolid Arthritis Activity & Severity

Session Type: Abstract Submissions (ACR)

Background/Purpose: Clinical assessment of disease activity is a routine procedure when evaluating individual rheumatoid arthritis (RA) patients in daily practice. Swollen joint count (SJC) and tender joint count (TJC) are traditionally performed by the physician (Ph) or the nurse. Patient (Pa) assessed joint count may be an advantage in the busy clinic. The reliability of DAS28 based on patient self-assessment of tender and swollen joints has not previously been reported. The objective of this study was to examine the agreement between patient and physician evaluation of SJC and TJC, to examine the agreement between physician and patient derived DAS28 and to evaluate the reproducibility of these measures when assessed by the physician and the patient, respectively.  

Methods: 30 out-clinic RA patients (mean age 60±15 years) with a disease duration of a least 5 years, who were familiar with physician joint counting and who were considered to have a stable and controlled disease activity were included. 28 TJC and SJC were assessed by patient self-evaluation and by an experienced specialist in rheumatology (the same specialist for all patients) on two different days (median interval 7 days, range 4–10 days) under standardised conditions. Patient global assessment (PaGA) (range 0-100) and CRP (mg/l) were also determined on both occasions. DAS28-CRP with four variables (4V) and three variables (3V) were calculated (1). The association between the duplicate measures was expressed by Pearson’s coefficient of correlation (r). Lower and upper limits of agreement (LOA) were calculated as the mean difference between scores of duplicate measurements (the bias) ± 1.96 x SD of these differences (2).

Results: The mean values for SJC, TJC, DAS(4V) and DAS(3V) based on Ph joint count versus Pa self-evaluation at the first visit was 3.7±2.4 vs. 3.6±3.2 (NS), 4.1±5.2 vs. 4.1±4.7 (NS), 3.5± 1.0 vs. 3.6±1.1 (NS) and 3.4±0.9 vs. 3.5±0.9 (NS). Mean values for CRP and PaGA were 7.9 ±6.5 and 33±28, respectively. Ph-DAS(4V) and Pa-DAS (4V) were highly correlated (r = 0.90, p < 0.0001), and so were corresponding DAS scores based on 3V (r = 0.85, p < 0.0001). The bias for Ph-DAS(4V) vs. Pa-DAS(4V) and associated lower and upper LOA were -0.1 (NS), -0.9 and +0.8, respectively. For DAS(3V) the corresponding results were -0.1 (NS), -1.1 and +0.9. The bias for the duplicate Pa-DAS(4V) assessments was -0.1 (NS) with lower and upper LOA of -0.9 and +0.8; and for Pa-DAS(3V) 0.0 (NS), -0.9 and +0.9. For duplicate Ph-DAS(4V) assessments the bias was 0.0 (NS), and LOA were -1.1 and +1.1. For Ph-DAS(3V) the corresponding figures were: 0.0 (NS), -1.2 and +1.2.

Conclusion: On group level, patient and physician derived DAS scores were in practical identical. Differences between patient and physician derived DAS on the individual level corresponded to the intra-rater agreement for both patients and physicians with LOA approximating ±1. Thus, patient-derived DAS seems to have suitable reliability and may therefore substitute traditional assessment by the physician, at least when the disease activity is stable.

Ref. 1. http://www.das-score.nl/www.das-score.nl/. Accessed 17 June 2011. 2. Altman DG, Bland JM. Lancet 1986; 1: 307-10.


Disclosure:

O. Rintek Madsen,
None;

C. Heegaard,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reliability-of-das28-in-rheumatoid-arthritis-when-based-on-patient-self-assessment-of-tender-and-swollen-joints/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology